FDA warns against compounding semaglutide
Time : 2nd of June 2023 04:00:38 PM
,
The agency received reports of adverse events after some patients used compounded semaglutide. Thus, FDA warned against using compounded drugs when an approved drug is available. Patients and physicians are urged to understand that such products may contain salt forms and FDA does not review the safety and effectiveness of compounded versions of drugs.
FDATags
FDA, semaglutide, warning, compoundedRecent Posts
Illicit drugs could be the reason behind 30% of sudden cardiac deaths
3rd of August 2023 02:58:31 PM
3rd of August 2023 02:58:31 PM
